Senseonics Holdings, Inc. cash flow statement
In fiscal 2025, Senseonics Holdings, Inc.'s operations generated −$59.1m of cash; it spent $1.1m on capital projects, leaving free cash flow of −$60.2m.
Cash flow statement
| Fiscal year | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −25 | −38 | −56 | −91 | −136 | −67 | −56 | −66 | −70 | −60 | −59 | −96 |
| Depreciation and amortisation | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Stock-based pay | 1 | 2 | 4 | 6 | 8 | 7 | 9 | 9 | 9 | 9 | 10 | 11 |
| Capital spending | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 2 | 1 | 1 |
| Free cash flow | −26 | −38 | −56 | −92 | −137 | −68 | −56 | −67 | −71 | −63 | −60 | −97 |
| Free cash flow after stock pay | −27 | −41 | −60 | −98 | −145 | −75 | −65 | −75 | −79 | −72 | −70 | −108 |
| Shares issued | — | 46 | 68 | 150 | 29 | — | — | — | — | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −15 | −14 | −16 | −9 | −16 | −18 | −32 | −30 |
| Depreciation and amortisation | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
| Stock-based pay | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 4 |
| Capital spending | −0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −15 | −14 | −17 | −9 | −16 | −18 | −32 | −30 |
| Free cash flow after stock pay | −17 | −16 | −18 | −12 | −19 | −21 | −34 | −34 |
| Shares issued | — | — | 26 | 72 | — | — | 3 | 50 |
Compare with peers
- Iridex Corp cash flow
- Clearpoint Neuro, Inc. cash flow
- Koru Medical Systems, Inc. cash flow
- Trisalus Life Sciences, Inc. cash flow
- Sanuwave Health, Inc. cash flow
Head to head: IRIX vs SENSCLPT vs SENSKRMD vs SENS
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies